MENU
+Compare
SYRE
Stock ticker: NASDAQ
AS OF
May 13, 04:59 PM (EDT)
Price
$14.76
Change
-$0.17 (-1.14%)
Capitalization
849.89M

SYRE Spyre Therapeutics Forecast, Technical & Fundamental Analysis

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection... Show more

SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SYRE with price predictions
May 12, 2025

SYRE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SYRE turned positive on April 17, 2025. Looking at past instances where SYRE's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where SYRE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 12, 2025. You may want to consider a long position or call options on SYRE as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SYRE advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SYRE broke above its upper Bollinger Band on April 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SYRE entered a downward trend on April 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SYRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.754) is normal, around the industry mean (14.767). P/E Ratio (1.716) is within average values for comparable stocks, (65.482). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.018). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (526.316) is also within normal values, averaging (254.233).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SYRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SYRE is expected to report earnings to rise 39.63% to -83 cents per share on July 31

Spyre Therapeutics SYRE Stock Earnings Reports
Q2'25
Est.
$-0.84
Q1'25
Beat
by $0.24
Q4'24
Beat
by $0.22
Q3'24
Missed
by $0.54
Q2'24
Beat
by $0.09
The last earnings report on May 08 showed earnings per share of -60 cents, beating the estimate of -83 cents. With 716.70K shares outstanding, the current market capitalization sits at 849.89M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEAX13.05N/A
N/A
MM S&P 500® Index R4
HBLTX14.38N/A
N/A
Hartford Balanced Income R5
REMYX17.04N/A
N/A
Russell Inv Emerging Markets Y
GWSAX16.74N/A
N/A
Gabelli Focused Gr and Inc A
WEMCX6.13N/A
N/A
Allspring Emerging Growth C

SYRE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+5.89%
BEAM - SYRE
56%
Loosely correlated
+4.77%
APGE - SYRE
52%
Loosely correlated
+6.14%
IDYA - SYRE
52%
Loosely correlated
+5.34%
CGON - SYRE
52%
Loosely correlated
+5.98%
IMNM - SYRE
50%
Loosely correlated
+6.43%
More